KEVIN FISHER to Humans
This is a "connection" page, showing publications KEVIN FISHER has written about Humans.
Connection Strength
0.295
-
Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression. Leuk Lymphoma. 2023 02; 64(2):462-467.
Score: 0.017
-
Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. Haematologica. 2022 08 01; 107(8):1880-1890.
Score: 0.016
-
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion. Pediatr Hematol Oncol. 2022 09; 39(6):580-585.
Score: 0.016
-
Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics. Pediatr Dev Pathol. 2020 Nov-Dec; 23(6):461-466.
Score: 0.014
-
Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis. Pediatr Hematol Oncol. 2020 Feb; 37(1):76-89.
Score: 0.013
-
Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type. Cold Spring Harb Mol Case Stud. 2018 10; 4(5).
Score: 0.012
-
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. J Mol Diagn. 2016 Mar; 18(2):299-315.
Score: 0.010
-
BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply. Hum Pathol. 2015 Jul; 46(7):1065-6.
Score: 0.010
-
Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):562-7.
Score: 0.009
-
Introduction: molecular genomics of cancer: linking diagnostic testing and clinical therapy. Curr Probl Cancer. 2014 Sep-Oct; 38(5):142-3.
Score: 0.009
-
Section II: hematolymphoid malignancies. Curr Probl Cancer. 2014 Sep-Oct; 38(5):159-74.
Score: 0.009
-
Section I: integrating laboratory medicine with tissue specimens. Curr Probl Cancer. 2014 Sep-Oct; 38(5):144-58.
Score: 0.009
-
Section III: molecular diagnostics in neuro-oncology. Curr Probl Cancer. 2014 Sep-Oct; 38(5):175-9.
Score: 0.009
-
Section IV: non-small cell lung cancer and malignant melanoma. Curr Probl Cancer. 2014 Sep-Oct; 38(5):180-98.
Score: 0.009
-
Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Hum Pathol. 2014 Nov; 45(11):2281-93.
Score: 0.009
-
Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol. 2014 Feb; 27(2):222-30.
Score: 0.009
-
Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma. J Surg Res. 2013 Nov; 185(1):217-24.
Score: 0.009
-
MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices. J Cell Sci. 2009 Dec 15; 122(Pt 24):4558-69.
Score: 0.007
-
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol Cancer. 2006 Dec 08; 5:69.
Score: 0.006
-
Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Jul-Aug; 27(4):348-353.
Score: 0.005
-
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study. Pediatr Hematol Oncol. 2023; 40(8):719-738.
Score: 0.004
-
A novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child. Pediatr Blood Cancer. 2023 03; 70(3):e29972.
Score: 0.004
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.004
-
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.
Score: 0.004
-
A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels. J Mol Diagn. 2022 07; 24(7):760-774.
Score: 0.004
-
Angiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2022 Apr 01; 44(3):e751-e755.
Score: 0.004
-
Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome. Cancer Genet. 2022 04; 262-263:53-56.
Score: 0.004
-
Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients. Haematologica. 2021 09 01; 106(9):2533-2536.
Score: 0.004
-
Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling. JCO Precis Oncol. 2021; 5.
Score: 0.004
-
Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series. Leuk Lymphoma. 2020 12; 61(14):3515-3518.
Score: 0.004
-
BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney. Pediatr Blood Cancer. 2020 04; 67(4):e28151.
Score: 0.003
-
Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency. Cold Spring Harb Mol Case Stud. 2019 10; 5(5).
Score: 0.003
-
Ponatinib use in two pediatric patients with relapsed Ph?+?ALL with ABL1 kinase domain mutations. Pediatr Hematol Oncol. 2019 11; 36(8):514-519.
Score: 0.003
-
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2019 10; 66(10):e27905.
Score: 0.003
-
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery. 2019 01; 165(1):58-63.
Score: 0.003
-
A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis. Pediatr Dev Pathol. 2018 Jan-Feb; 21(1):100-104.
Score: 0.003
-
The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol. 2018 Feb; 36(1):307-315.
Score: 0.003
-
Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp. Int J Gynecol Pathol. 2016 May; 35(3):249-55.
Score: 0.003
-
Development and validation of CALR mutation testing for clinical diagnosis. Am J Clin Pathol. 2015 Nov; 144(5):738-45.
Score: 0.003
-
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. Mol Cell. 2015 Aug 06; 59(3):345-358.
Score: 0.002
-
The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer. Appl Immunohistochem Mol Morphol. 2015 Apr; 23(4):239-44.
Score: 0.002
-
BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression. Appl Immunohistochem Mol Morphol. 2014 Oct; 22(9):648-51.
Score: 0.002
-
HER2 in resected gastric cancer: Is there prognostic value? J Surg Oncol. 2014 Feb; 109(2):61-6.
Score: 0.002
-
The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist? J Am Coll Surg. 2013 Nov; 217(5):881-8.
Score: 0.002
-
Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma. Cancer. 2013 Sep 01; 119(17):3242-50.
Score: 0.002
-
Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy. Cancer. 2013 Jan 15; 119(2):454-62.
Score: 0.002
-
Endothelial lumen signaling complexes control 3D matrix-specific tubulogenesis through interdependent Cdc42- and MT1-MMP-mediated events. Blood. 2010 Jun 24; 115(25):5259-69.
Score: 0.002
-
Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood. 2009 Jul 09; 114(2):237-47.
Score: 0.002